연구성과로 돌아가기

2021 연구자 정보 (16 / 1146)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Oh, Soo A.
(Oh, SA) ⓘ 		Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Clonal dynamics in early human embryogenesis inferred from somatic mutation ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ ohjiwon@knu.ac.kr;ysju@kaist.ac.kr; ⓘ
Park, Jung Min
(Park, JM) ⓘ 		Kyungpook Natl Univ, Sch Med, Dept Anat, Daegu, South Korea
Immune Sq Inc, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Clonal dynamics in early human embryogenesis inferred from somatic mutation ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ ohjiwon@knu.ac.kr;ysju@kaist.ac.kr; ⓘ
Park, Jung Woo
(Park, JW) ⓘ 		Korea Inst Sci & Technol Informat KISTI, Daejeon, South Korea ⓘ
ⓘ 		0000-0001-8230-1787
Park, Jung Woo ⓘ 		[JCR상위 0.7] Clonal dynamics in early human embryogenesis inferred from somatic mutation ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ ohjiwon@knu.ac.kr;ysju@kaist.ac.kr; ⓘ
Park, Seongyeol
(Park, S) ⓘ 		제1저자 Korea Adv Inst Sci & Technol KAIST, Grad Sch Med Sci & Engn GSMSE, Daejeon, South Korea
GENOME INSIGHT Inc, Daejeon, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Clonal dynamics in early human embryogenesis inferred from somatic mutation ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ ohjiwon@knu.ac.kr;ysju@kaist.ac.kr; ⓘ
Piskol, Robert
(Piskol, R) ⓘ 		Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Qiao, Qiquan
(Qiao, QQ) ⓘ 		교신저자 South Dakota State Univ, Ctr Adv Photovolta, Dept Elect Engn, Brookings, SD 57007 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics ⓘ SCIE ⓘ 0.7 CHEMISTRY, APPLIED;CHEMISTRY, PHYSICAL;ENERGY & FUELS;ENGINEERING, CHEMICAL ⓘ SaiAnand.Gopalan@newcastle.edu.au;Quinn.Qiao@sdstate.edu; ⓘ
Redington, Alison L.
(Redington, AL) ⓘ 		Met Off, Hadley Ctr, Exeter, Devon, England ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] A decline in emissions of CFC-11 and related chemicals from eastern China ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ Luke.western@bristol.ac.uk;rprinn@mit.edu;matt.rigby@bristol.ac.uk; ⓘ
Reza, Khan Mamun
(Reza, KM) ⓘ 		South Dakota State Univ, Ctr Adv Photovolta, Dept Elect Engn, Brookings, SD 57007 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics ⓘ SCIE ⓘ 0.7 CHEMISTRY, APPLIED;CHEMISTRY, PHYSICAL;ENERGY & FUELS;ENGINEERING, CHEMICAL ⓘ SaiAnand.Gopalan@newcastle.edu.au;Quinn.Qiao@sdstate.edu; ⓘ
Saito, Takuya
(Saito, T) ⓘ 		Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] A decline in emissions of CFC-11 and related chemicals from eastern China ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ Luke.western@bristol.ac.uk;rprinn@mit.edu;matt.rigby@bristol.ac.uk; ⓘ
Segal, Ehud
(Segal, E) ⓘ 		Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Shanahan, Frances
(Shanahan, F) ⓘ 		Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Shin, Sang Joon
(Shin, SJ) ⓘ 		Yonsei Univ, Dept Internal Med, Div Med Oncol, Coll Med, Seoul, South Korea
Yonsei Univ, Dept Internal Med, Div Oncol, Coll Med, Seoul, South Korea ⓘ
ⓘ 		0000-0001-5350-7241
Shin, Sang Joon ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma
[JCR상위 43.9] 2020 Korean guidelines for the management of metastatic prostate cancer ⓘ 		SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES
MEDICINE, GENERAL & INTERNAL ⓘ 		twkimmd@amc.seoul.kr;shivam@gene.com;
cymed@cnu.ac.kr; ⓘ
Srinivasan, Shrividhya
(Srinivasan, S) ⓘ 		Genentech Inc, Dept Oncol Biomarker Dev, San Francisco, CA 94080 USA ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Sudhamsu, Jawahar
(Sudhamsu, J) ⓘ 		Genentech Inc, Dept Discovery Oncol, San Francisco, CA 94080 USA
Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA ⓘ
ⓘ 		0000-0003-0737-2299
Sudhamsu, Jawahar ⓘ 		[JCR상위 0.7] ARAF mutations confer resistance to the RAF inhibitor belvarafenib in melanoma ⓘ SCIE ⓘ 0.7 MULTIDISCIPLINARY SCIENCES ⓘ twkimmd@amc.seoul.kr;shivam@gene.com; ⓘ
Unni, Gautam E.
(Unni, GE) ⓘ 		Newcastle Energy Ctr, CSIRO Energy, 10 Murray Dwyer Cct, Mayfield West, NSW 2304, Australia
Univ Newcastle, Fac Engn & Built Environm, Callaghan, NSW 2308, Australia ⓘ
ⓘ
ⓘ 		[JCR상위 0.7] Current advancements on charge selective contact interfacial layers and electrodes in flexible hybrid perovskite photovoltaics ⓘ SCIE ⓘ 0.7 CHEMISTRY, APPLIED;CHEMISTRY, PHYSICAL;ENERGY & FUELS;ENGINEERING, CHEMICAL ⓘ SaiAnand.Gopalan@newcastle.edu.au;Quinn.Qiao@sdstate.edu; ⓘ
페이지 이동: